| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/15/2009 | EP2046370A2 Treatment of pain by use of a single chain polypeptide fusion protein |
| 04/15/2009 | EP2046369A2 Recombinant host for producing l-asparaginase ii |
| 04/15/2009 | EP2046368A2 Anti-cocaine compositions and treatment |
| 04/15/2009 | EP2046367A2 Albumin fusion proteins |
| 04/15/2009 | EP2046366A2 Method of treatment of age-related macular degeneration |
| 04/15/2009 | EP2046365A1 Pharmaceutical composition for treating autoimmune, allergic and inflammatory diseases and delivery method thereof |
| 04/15/2009 | EP2046364A2 Use of wnt5a for inhibiting scarring |
| 04/15/2009 | EP2046363A1 Antimicrobial peptides |
| 04/15/2009 | EP2046362A1 Formulation comprising whey protein and hydrolysates for improving muscle recovery |
| 04/15/2009 | EP2046361A2 Osteogenic enhancer composition |
| 04/15/2009 | EP2046323A2 Methods, compositions and articles of manufacture for contributing to the treatment of cancers |
| 04/15/2009 | EP2046317A2 Compositions and methods of reducing tissue levels of drugs when given as orotate derivatives |
| 04/15/2009 | EP2046284A1 Compositions for intranasal delivery of human insulin and uses thereof |
| 04/15/2009 | EP2046135A2 Polyphenol/peptide composition and use thereof for promoting gastric health |
| 04/15/2009 | EP1937799A4 Compositions and methods for culturing embryos and oocytes |
| 04/15/2009 | EP1817056A4 Parathyroid hormone receptor activation and stem and progenitor cell expansion |
| 04/15/2009 | EP1719773B1 Fused heterotetracyclic compounds and use tehreof as hcv polymerase inhibitor |
| 04/15/2009 | EP1629007B1 Novel peptides that bind to the erythropoietin receptor |
| 04/15/2009 | EP1562628B1 Dc-sign blockers and their use for preventing or treating viral infections. |
| 04/15/2009 | EP1528930B1 Pharmaceutically active substance preparations and drugs that are capable of generating thrombin and/or that contain thrombin |
| 04/15/2009 | EP1458408B1 Liquid composition of factor vii polypeptides |
| 04/15/2009 | EP1417307B1 Oligonucleotide compositions and their use to induce apoptosis |
| 04/15/2009 | EP1390490B1 Muscle-specific expression vectors |
| 04/15/2009 | EP1373506B1 Yeast strain of saccharomyces cerevisiae with functional expression of a glut transporter |
| 04/15/2009 | EP1334196B1 Genomic fragment of streptococcus suis and clinical uses thereof |
| 04/15/2009 | EP1333880B1 Transdermal drug delivery devices having coated microprotrusions |
| 04/15/2009 | EP1326969B1 Improved system for regulation of transgene expression |
| 04/15/2009 | EP1325145B1 Adenoviral vectors for gene delivery in skeletal muscle cells or myoblasts |
| 04/15/2009 | EP1258251B1 Compositions for preventing and treating digestive diseases |
| 04/15/2009 | EP1257295B1 Factor vii or viia-like molecules |
| 04/15/2009 | EP1216296B1 Bioengineered collagen fibrils |
| 04/15/2009 | EP1203007B1 Nucleic acid ligands to hepatocyte growth factor/scatter factor (hgf/sf) and its receptor c-met |
| 04/15/2009 | EP1161452B1 Covalently bridged insulin dimers |
| 04/15/2009 | EP1079854B1 Compositions and methods of modulating an immune response to an antigen by administration of cytokine-coated cells |
| 04/15/2009 | EP1012267B1 An antisense oligonucleotide preparation method |
| 04/15/2009 | EP0792292B2 Estrogen receptor |
| 04/15/2009 | CN101410409A Immunomodulating composition |
| 04/15/2009 | CN101410408A A process for concentration of a polypeptide |
| 04/15/2009 | CN101410140A Engineered antibody-stress protein fusions |
| 04/15/2009 | CN101410139A Use of the staudinger ligation in in vivo assembly of a biologically active compound |
| 04/15/2009 | CN101410132A GDF-9/BMP-15 modulators for the treatment of bone disorders |
| 04/15/2009 | CN101410131A Lipid-metabolism-improving agent |
| 04/15/2009 | CN101410130A Novel immunomodulating peptide |
| 04/15/2009 | CN101407815A Preparing method of glycine-N-methyltransferase (GNMT) knockout mouse model and use thereof |
| 04/15/2009 | CN101407812A Heterologous expression and purification method for human RANTES protein having chemotaxis |
| 04/15/2009 | CN101407801A Preparation of earthworm fibrinolytic enzyme from Pheretima guillelmi Michaelsen and lyophilized powder preparation for injection prepared thereby |
| 04/15/2009 | CN101407796A Recombinant alpha-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof |
| 04/15/2009 | CN101407792A Preparation of pit viper bioactivity enzyme |
| 04/15/2009 | CN101407539A Oligopeptide having marrow hemopoiesis protection function, preparation thereof, pharmaceutical composition containing the oligopeptide and use |
| 04/15/2009 | CN101406695A Pharmaceutical composition for promoting axon regeneration after spinal cord damage and behavior function recovery |
| 04/15/2009 | CN101406694A Formulation for increasing bone density and preparation thereof |
| 04/15/2009 | CN101406693A Use of pharmaceutical composition for treating cardiovascular disease in preparing medicament for protecting endothelial cell damage |
| 04/15/2009 | CN101406692A Vaccine composition containing transforming growth factor alpha |
| 04/15/2009 | CN101406691A Melittin complex nanometer granule for oral dosing and preparation method thereof |
| 04/15/2009 | CN101406690A Medicament for promoting regeneration and repair after neurologic damage |
| 04/15/2009 | CN101406689A Method for producing liver-boosting capsule containing glutathione and other nine ingredients |
| 04/15/2009 | CN101406458A Biodegradable polyester medicine-carrying microsphere of mimetic peroxidase and preparation method |
| 04/15/2009 | CN101406453A Pharmaceutical compositions for oral and topical administration |
| 04/15/2009 | CN101406452A Ciclosporin A microemulsion formulation for injection and preparation method thereof |
| 04/15/2009 | CN100478689C Polypeptide and use thereof |
| 04/15/2009 | CN100478636C Mounting arrangement for auxiliary burner or lance |
| 04/15/2009 | CN100478439C Prawn antiviral growth-promoting double-function engineering strain, construct method and application |
| 04/15/2009 | CN100478359C Polyethylene glycol-interferon coupler and its preparation method |
| 04/15/2009 | CN100478349C Nucleoside fluoride compound, its production and use |
| 04/15/2009 | CN100478033C Medicine comprising HGF gene |
| 04/15/2009 | CN100478030C SARS resisting medicine action target and its preventing and treating medicine |
| 04/15/2009 | CN100478029C Immunomodulatory human MHC class II antigen-binding polypeptides |
| 04/15/2009 | CN100478027C Catheter composition and uses thereof for preparing medicine |
| 04/15/2009 | CN100478026C Delivery system for biological component |
| 04/15/2009 | CN100478025C Cyclosporia A microemulsion for eye and its preparation method |
| 04/14/2009 | US7517974 Blood coagulation factor; nucleotide sequence encodes polypeptide; amino acid sequence differs in 1-15 amino acid residues and comprises an introduced in vivo N-glycosylation site; substitution V253N; coagulation related disorders |
| 04/14/2009 | US7517972 Nucleic acid sequences encoding a bitter taste receptor, T2R76 |
| 04/14/2009 | US7517971 Muteins of human telomerase reverse transcriptase lacking telomerase catalytic activity |
| 04/14/2009 | US7517966 antibodies that bind polypeptides that are prefrentially expressed by all mature NK cells, used for medical diagnosis, prevention of viral and microbial infections, and as antitumor agents |
| 04/14/2009 | US7517963 Tumour necrosis factor binding ligands |
| 04/14/2009 | US7517962 TWEAK receptor |
| 04/14/2009 | US7517961 Homogeneous preparations of IL-28 and IL-29 |
| 04/14/2009 | US7517960 comprising polypeptides, fusion proteins, dimers and tetramers, useful for identification and development of activators and inhibitors for treating nervous system disorders |
| 04/14/2009 | US7517959 suppressor of cytokine signalling 3 (SOCS3) proteins, which has a deletion/inactivation aof the proline-, glutamic acid-, serine- and threonine-rich (PEST) domain peptide; inhibitors of leukemia-inhibitory factor-induced signal transducer and activator of transcription activity; gene and protein therapy |
| 04/14/2009 | US7517957 Human SLAP-2: a novel SH2/ SH3 domain-containing human SLAP homologue having immune cell-specific expression |
| 04/14/2009 | US7517955 Lactoferrin binding protein for use in diagnosis, treatment and prevention of streptococcal pathogen infection |
| 04/14/2009 | US7517951 Marker proteins for diagnosing liver disease and method of diagnosing liver disease using the same |
| 04/14/2009 | US7517950 polypeptide that binds to major histocompatibility complex (MHC) proteins and induces cytotoxic t lymphocytes when bound to MHC antigens; anticancer vaccines |
| 04/14/2009 | US7517949 Livin-derived peptides, compositions and uses thereof |
| 04/14/2009 | US7517948 Hsp70 peptide stimulating natural killer (NK) cell activity and uses thereof |
| 04/14/2009 | US7517870 Use of compounds that interfere with the hedgehog signaling pathway for the manufacture of a medicament for preventing, inhibiting, and/or reversing ocular diseases related with ocular neovascularization |
| 04/14/2009 | US7517866 LIM mineralization protein splice variants |
| 04/14/2009 | US7517860 Inhibition of lipoprotein secretion |
| 04/14/2009 | US7517858 Prodrugs of pharmaceuticals with improved bioavailability |
| 04/14/2009 | US7517857 Binding to formyl peptide receptor or formyl peptide receptor-like 1; induce superoxide generation by human monocytes or neutrophils; induce chemotactic migration of human monocytes or neutrophils in vitro; that induce degranulation in formyl peptide receptor expressing cells or formyl peptide receptor-l |
| 04/14/2009 | US7517856 Bioactive polypeptide conjugated to the sulfate group; sustained release; anticancer; alginate sulfate or sulfated hyaluronan conjugated to e.g. insulin, glatiramer acetate, antithrombin III, interferon gamma , IGF, somatostatin, luteinizing hormone-releasing hormone, erythropoietin, interleukins |
| 04/14/2009 | US7517855 Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereof |
| 04/14/2009 | US7517854 Melanocortin receptor agonists |
| 04/14/2009 | US7517853 Biodrugs for treatment of neoplasia and acromegaly |
| 04/14/2009 | US7517852 Compositions and methods for treating bacteria |
| 04/14/2009 | US7517851 Carbohydrate containing mannose; prevent binding of chlamydia to mammal cells |
| 04/14/2009 | US7517850 Calcium phosphate nanoclusters and their applications |
| 04/14/2009 | US7517849 ATP-binding cassette transporter protein-inhibiting peptide; impair the functioning of the ABC transporter responsible for conferring resistance to chemotherapeutic agents cancer cells, rendering them more susceptible to killing by standard chemotherapeutic agents; 1st peptide end negatively charged |
| 04/14/2009 | US7517676 polynucleotide comprising a DNA sequence that codes for a polypeptide having oxidoreductase enzyme activity, used in detection assays, gene therapy, and screening assays |
| 04/14/2009 | US7517672 Nucleic acids encoding mammalian T-type calcium channels |